基本信息
-
1-[(2''-[(乙氧羰基)氧基]脒基)[1,1-联苯基]-4-基)甲基]-2-乙氧
-
147403-52-9
-
1-[(2'-[(乙氧羰基)氧基]脒基)[1,1-联苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯; 阿齐沙坦-a04;
-
C26H22N4O5
-
470.47700
-
methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
-
692-146-2
-
1.36
-
methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate;1H-Benzimidazole-7-carboxylic acid,1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-,methyl ester;methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;methyl 1-[[2'-(4,5-dihydro-5-oxo-4H-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate;methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;BEN731;查看更多英文别名收起
-
-
-
-
详细信息
英文名称: 1H-BenziMidazole-7-carboxylic acid, 1-[[2''-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1''-biphenyl]-4-yl]Methyl] -2-ethoxy-, Methyl ester
中文名称: 1-[(2''-[(乙氧羰基)氧基]脒基)[1,1-联苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯
MF: C26H22N4O5
MW: 470.47668
CAS: 147403-52-9
公司简介
北京捷瑞斯医药科技有限公司(简称“捷瑞斯医药”),是一家专业生产销售医药中间体的厂家, 目前在产产品为西尼必利中间体,加雷沙星中间体,芬戈莫德中间体,卢非酰胺中间体,托伐普坦中间体,多佐胺中间体,卡立普多中间体,阿齐沙坦中间体,鲁拉西酮中间体,艾普拉唑中间体
,度洛西汀中间体等。公司一贯坚持“质量,用户至上,优质服务,信守合同”的宗旨,高质量的产品,良好的信誉,优质的服务,竭诚与国内外商家双赢合作,共同发展,共创辉煌!